You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Antimicrobial Resistance (AMR)

Test Information

Antimicrobial resistance (AMR) leads to longer hospital stays, increased mortality, and higher medical costs.

AMR is one of the top 10 global public health threats facing humanity, with misuse and overuse of antimicrobials being the main drivers in the development of drug-resistant pathogens. In addition to death and disability, prolonged illness results in longer hospital stays and financial challenges for those impacted.1

Why AMR Matters:

2.8 Million
infections annually1

35,000
deaths annually in the U.S.2

4.6 Billion
in extra healthcare costs3

Relationship to Healthcare-Associated Infections (HAIs)4,5

HAIs are frequently caused by drug-resistant bacteria. HAIs can:

1 in 3
bacteria associated with HAIs are resistant to antibiotics4

4.5 Million
annual number of patients with at least one HAI5

1 in 15
number of patients on any given day with at least one HAI4

Everyone is at Risk6

Some, however, are high-risk and disproportionally impacted:

Patients undergoing cancer therapy

Patients with weakened immune systems

Patients undergoing dialysis

Patients undergoing complex surgery

How We Can Build Better Antibiotic Stewardship with the GeneXpert® System

With on-demand molecular diagnostics, today’s healthcare providers are able to quickly identify whether an infection is present and if it is drug-resistant, in minutes, rather than days. Cepheid’s GeneXpert® system helps those on the frontlines of resistance prevent the inappropriate use of antimicrobials and preserve our antibiotic weapons―now and in the future. For more information, download our antimicrobial stewardship brochure.

 

Download AMR Infographic Brochure

Related White Papers & Webinars

Connect To Better Outcomes

Request Info
1 Centers for Disease Control and Prevention: Antibiotic Resistance Threats in the United States, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
Accessed April 18, 2022.
2 World Health Organization: Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed April 18, 2022.
3 Centers for Disease Control and Prevention: CDC Study Shows National Healthcare Costs from AR Infections Exceed $4.6 Billion. https://www.cdc.gov/ncezid/what-we-do/partnership-in-
action/healthcare-costs-associated-with-ar-infections.html. Accessed April 18, 2022.
4 MedTech Europe. 2014. Healthcare-Associated Infections Brochure. Accessed Feb 2021. https://www.medtecheurope.org/resource-library/hai-brochure/
5 ECDC. 2018. Healthcare-Associated Infections - A Threat to Patient Safety in Europe. Accessed Feb 2021.
https://www.ecdc.europa.eu/en/publications-data/infographichealthcare-associated-infections-threat-patient-safety-europe
6 CDC. 2019. Antibiotic Resistance Threats in the United States 2019. Accessed Feb 2021. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf 
7 World Health Organization. “Antimicrobial resistance: global report on surveillance.” June, 2014.
Back to Top